TY - JOUR
T1 - Genetic and Depressive Traits Moderate the Reward-Enhancing Effects of Acute Nicotine in Young Light Smokers
AU - Whitton, Alexis E.
AU - Rabinovich, Norka E.
AU - Lindt, John D.
AU - Pergadia, Michele L.
AU - Pizzagalli, Diego A.
AU - Gilbert, David G.
N1 - Funding Information:
Research reported in this publication was supported by R01 DA036032 from the National Institute of Drug Abuse (to DGG). DAP was partially supported by R01MH101521 and R37 MH068376 from the National Institute of Mental Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. AEW received support from the National Health and Medical Research Council, Grant No. GNT1110773.
Publisher Copyright:
© The Author(s) 2021. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved.
PY - 2021/10/1
Y1 - 2021/10/1
N2 - Introduction: Rates of light smoking have increased in recent years and are associated with adverse health outcomes. Reducing light smoking is a challenge because it is unclear why some but not others, progress to heavier smoking. Nicotine has profound effects on brain reward systems and individual differences in nicotine’s reward-enhancing effects may drive variability in smoking trajectories.Therefore, we examined whether a genetic risk factor and personality traits known to moderate reward processing, also moderate the reward-enhancing effects of nicotine. Methods: Light smokers (n = 116) performed a Probabilistic RewardTask to assess reward responsiveness after receiving nicotine or placebo (order counterbalanced). Individuals were classified as nicotine dependence ‘risk’ allele carriers (rs16969968 A-allele carriers) or non-carriers (non-A-allele carriers), and self-reported negative affective traits were also measured. Results: Across the sample, reward responsiveness was greater following nicotine compared to placebo (p = 0.045). For Caucasian A-allele carriers but not non-A-allele carriers, nicotine enhanced reward responsiveness compared to placebo for those who received placebo first (p = 0.010). Furthermore, for A-allele carriers but not non-A-allele carriers who received nicotine first, the enhanced reward responsiveness in the nicotine condition carried over to the placebo condition (p < 0.001). Depressive traits also moderated the reward-enhancing effects of nicotine (p = 0.010) and were associated with blunted reward responsiveness following placebo but enhanced reward responsiveness following nicotine. Conclusion: These findings suggest that individual differences in a genetic risk factor and depressive traits alter nicotine’s effect on reward responsiveness in light smokers and may be important factors underpinning variability in smoking trajectories in this growing population. Implications: Individuals carrying genetic risk factors associated with nicotine dependence (rs16969968 A-allele carriers) and those with higher levels of depressive personality traits, show more pronounced increases in reward learning following acute nicotine exposure.These findings suggest that genetic and personality factors may drive individual differences in smoking trajectories in young light smokers by altering the degree to which nicotine enhances reward processing. Clinical trial registration: NCT02129387 (pre-registered hypothesis: www.clinicaltrials.gov)
AB - Introduction: Rates of light smoking have increased in recent years and are associated with adverse health outcomes. Reducing light smoking is a challenge because it is unclear why some but not others, progress to heavier smoking. Nicotine has profound effects on brain reward systems and individual differences in nicotine’s reward-enhancing effects may drive variability in smoking trajectories.Therefore, we examined whether a genetic risk factor and personality traits known to moderate reward processing, also moderate the reward-enhancing effects of nicotine. Methods: Light smokers (n = 116) performed a Probabilistic RewardTask to assess reward responsiveness after receiving nicotine or placebo (order counterbalanced). Individuals were classified as nicotine dependence ‘risk’ allele carriers (rs16969968 A-allele carriers) or non-carriers (non-A-allele carriers), and self-reported negative affective traits were also measured. Results: Across the sample, reward responsiveness was greater following nicotine compared to placebo (p = 0.045). For Caucasian A-allele carriers but not non-A-allele carriers, nicotine enhanced reward responsiveness compared to placebo for those who received placebo first (p = 0.010). Furthermore, for A-allele carriers but not non-A-allele carriers who received nicotine first, the enhanced reward responsiveness in the nicotine condition carried over to the placebo condition (p < 0.001). Depressive traits also moderated the reward-enhancing effects of nicotine (p = 0.010) and were associated with blunted reward responsiveness following placebo but enhanced reward responsiveness following nicotine. Conclusion: These findings suggest that individual differences in a genetic risk factor and depressive traits alter nicotine’s effect on reward responsiveness in light smokers and may be important factors underpinning variability in smoking trajectories in this growing population. Implications: Individuals carrying genetic risk factors associated with nicotine dependence (rs16969968 A-allele carriers) and those with higher levels of depressive personality traits, show more pronounced increases in reward learning following acute nicotine exposure.These findings suggest that genetic and personality factors may drive individual differences in smoking trajectories in young light smokers by altering the degree to which nicotine enhances reward processing. Clinical trial registration: NCT02129387 (pre-registered hypothesis: www.clinicaltrials.gov)
UR - https://www.scopus.com/pages/publications/85116957142
U2 - 10.1093/ntr/ntab072
DO - 10.1093/ntr/ntab072
M3 - Article
C2 - 33844007
AN - SCOPUS:85116957142
SN - 1462-2203
VL - 23
SP - 1779
EP - 1786
JO - Nicotine and Tobacco Research
JF - Nicotine and Tobacco Research
IS - 10
ER -